Horizon Therapeutics Public Ltd Co

Private Advisor Group, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/3/2023

Shares

6,368

Value ($000)

737

Weight

0.0%

2019 Q4 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/3/2023	737	0.0%	6,368	9/30/2023
2023 Q2	8/10/2023	654	0.0%	6,363	6/30/2023
2023 Q1	5/10/2023	691	0.0%	6,334	3/31/2023
2022 Q3	10/14/2022	401	0.0%	6,481	9/30/2022
2022 Q2	7/13/2022	6,940	0.1%	87,018	6/30/2022
2022 Q1	5/12/2022	4,707	0.0%	44,740	3/31/2022
2021 Q4	2/10/2022	7,749	0.1%	71,914	12/31/2021
2021 Q3	10/14/2021	12,509	0.1%	114,196	9/30/2021
2021 Q2	8/12/2021	5,996	0.1%	64,040	6/30/2021
2021 Q1	4/22/2021	5,434	0.1%	59,043	3/31/2021
2020 Q4	4/1/2021	3,764	0.0%	51,456	12/31/2020
2020 Q3	11/2/2020	779	0.0%	10,025	9/30/2020
2020 Q2	8/17/2020	524	0.0%	9,424	6/30/2020
2020 Q1	5/12/2020	279	0.0%	9,424	3/31/2020
2019 Q4	2/10/2020	321	0.0%	8,879	12/31/2019